Funding · Healthcare & Life Sciences
Wholeleaf in advanced talks to raise Rs 7.5 crore
By Startup Enthusiast ·
- Date
- Company
- Wholeleaf
- What it does
- Natural pain therapeutics company
- Kind
- Funding
- Amount
- Rs 5 crore
- Stage
- seed
- Founded
- 2021
What they do
Wholeleaf makes medically oriented natural pain therapeutics for chronic and neuropathic pain
What happened
It is in advanced talks to raise Rs 7.5 crore from IPV and Benzai 10 Capital
Why it matters
The company has an annual recurring revenue of Rs 18 crore and nearly 2,000 retail outlets
The details
- Wholeleaf is in advanced talks to raise Rs 7.5 crore from IPV and Benzai 10 Capital.
- The company makes medically oriented natural pain therapeutics.
- It focuses on chronic and neuropathic pain management.
- Wholeleaf leads the cannabinoid pain therapeutics category in India.
- Its portfolio includes oral tinctures and topical formulations for migraines, arthritis, fibromyalgia, menstrual pain, anxiety, and sleeplessness.
- The company has a pipeline for chronic neuropathic pain solutions.
- It has raised Rs 5 crore to date, including a seed round of Rs 1.5 crore from Shark Tank India investors and Rs 3.5 crore from ah! Ventures and angels.
The bigger picture
- It will also scale distribution and enhance brand visibility both online and offline.
- The company plans to expand from nearly 2,000 retail outlets to 5,000–7,000 this year.
- Target cities for deeper penetration include Bengaluru, Mumbai, Hyderabad, Kolkata, Ahmedabad, Goa, and Chennai.
About the business
- Wholeleaf is a medically oriented natural pain therapeutics company launched in 2021.
- It focuses on chronic and neuropathic pain management.
- The company leads the cannabinoid pain therapeutics category in India.
- Its product portfolio includes oral tinctures and topical formulations for migraines, arthritis, fibromyalgia, menstrual pain, anxiety, and sleeplessness.
- Wholeleaf has a pipeline for chronic neuropathic pain solutions.
- Product development is physician-led with multi-stage validation including safety testing, pilot studies, and third-party government-certified lab assessments.
- The company has nearly 2,000 retail outlets, primarily in Delhi-NCR.
- It has an annual recurring revenue of Rs 18 crore.
What happens next
- Wholeleaf plans to use the funds to accelerate offline retail expansion, strengthen product development, scale distribution, and enhance brand visibility online and offline.
- It aims to expand from nearly 2,000 retail outlets to 5,000–7,000 this year.
- Target cities for deeper penetration include Bengaluru, Mumbai, Hyderabad, Kolkata, Ahmedabad, Goa, and Chennai.
The deal
- Type
- funding
Investors
- IPV (participated) — IPV is an institutional investor participating in this round.
- Benzai 10 Capital (participated) — Benzai 10 Capital is an institutional investor participating in this round.
Founders
- Shivraj Sharma, Founder and CEO
More on Wholeleaf
- Wholeleaf plans to expand retail outlets significantly29 May 2026 · Launch
- Wholeleaf founder discusses growth and science15 April 2026 · Analysis
- Wholeleaf raises Rs 1.5 crore from Shark Tank India investors26 February 2026 · Funding · Rs 1.5 crore
- Wholeleaf site blocked in France for lack of license1 February 2026 · Legal
Same day
- ABFRL lifts Bewakoof stake to 99%8 June 2026 · Stake sale
- Aye Finance to raise up to $15 Mn through listed non-convertible debentures8 June 2026 · Funding · $15 Mn
- Aurus Inc appoints Rishabh Jain as SVP for India8 June 2026 · People
- AI filmmaking tools and projects emerge across India8 June 2026 · Analysis
- Rebalance launches tenth cohort for women founders8 June 2026 · Launch
- Apna launches AI interview prep lounge in Mumbai8 June 2026 · Launch